Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion type Assertion NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_head.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_provenance.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion evidence source_evidence_literature NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_provenance.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion SIO_000772 18807035 NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_provenance.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion wasDerivedFrom befree-20150227 NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_provenance.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion wasGeneratedBy ECO_0000203 NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_provenance.